The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain ...
Abbott will soon enter the competitive U.S. pulsed field ablation (PFA) market, having just received FDA approval for its Volt PFA System to treat atrial fibrillation. The highly anticipated ...
The Volt PFA system. [Image courtesy of Abbott] Abbott (NYSE: ABT) + announced today that the FDA approved its Volt pulsed field ablation (PFA) system to treat patients with AFib. Abbott said it plans ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback